This result, along with its poor performance after its partner's erroneous choice (Fig. 2C , upper panels), supports the idea that monkey E's determined its choice on the basis of only reward information, regardless of the color selected by the partner. Taking the consistent reaction times subsequent to all types of no-reward trial ( fig. S3 ) into consideration, monkey E seemed to have developed a unique, systemized and automatic strategy (6) with which monitoring or utilizing the information of others' performance was not required, whereas monkeys N and S utilized the information of both reward and their partner's choice to determine their choices. To obtain the maximum reward, however, it was better for monkey E to observe its partner's choice. The possible reasons why monkey E used this strategy are the following: 1) it was somehow difficult for monkey E to monitor or utilize others' behavior owing, for example, to a lack of interest in others' behavior or incapability to shift its attention quickly between itself and its partner, as with autistic persons who have impaired rapid shifting of attention, 2) monkey E had no idea that its partner's behavior could have an impact on its reward outcome, and 3) monkey E felt more comfortable when following its own systemized strategy, which could be considered as an obsession with systems.
Monkey E's behavior in the early stage of task training is also noteworthy. After the monkeys had learned that pressing a button would bring a reward, we had the monkeys learn that choosing yellow from two colors (yellow and green, the positions of which randomly changed) would bring a reward. After they had successfully learned it, we then switched the color associated with a reward from yellow to green. Monkeys N and S by and by learned that yellow was no longer associated with a reward and tried pressing a green button. However, monkey E never tried pressing a green button but continued choosing yellow without getting any reward. Even when an experimenter hid a yellow button or guided its forearm to a green button, it made every effort not to touch it. This behavior of monkey E could be regarded as insistence on sameness or hyperreactivity to sensory input (color), which is mentioned as the core features of ASD in DSM-5.
As the monkeys were housed in individual cages, affiliative behaviors between them were not naturally observed. However, when the experimenters without any food for them visited, monkeys N and S in their cages usually came close and stopped there with their bodies pressed against the cage bars as if waiting to be groomed, or sometimes showed the buttocks. These behaviors are interpreted as presenting for grooming and presenting for mounting. Monkey E never displayed such behaviors.
Relationships between ABCA13 disruptions and mental disorders
It has been documented that disruptions of ABCA13 can be associated with mental disorders. Specifically, a patient with chronic schizophrenia was found to carry a complex chromosomal rearrangement comprising an inversion of chromosome 7 as well as a translocation between chromosomes 7 and 8, which directly disrupted ABCA13 (12). Resequencing analyses of ABCA13 exons revealed that the frequency of 10 rare nonsynonymous mutations (1 nonsense and 9 missense) was significantly higher in schizophrenia and bipolar disorder patients than in controls (12). A further test showed that in families of mutation carriers, there was a significant linkage between these rare variants and schizophrenia, bipolar disorder, and major depression (12). Disruptions of ABCA13 may also be linked to neurodevelopmental disorders. Two independent studies have identified exonic de novo point mutations in ABCA13 in ASD patients, namely, two missense mutations found by analyses in family quads (13) and one missense mutation in family trios (14).
ABCA13, located on chromosome 7 in humans, encodes the ATP-binding cassette (ABC) protein A13, a member of the ABCA protein subfamily (59). In the human brain, ABCA13 mRNA is expressed in the cortex and hippocampus (12). In rodents, the ABCA13 protein is found in cells in most brain regions but particularly in dentate gyrus granule cells, ventricular ependymal cells, cerebral cortical cells, and cerebellar Purkinje cells (11, 12) . Many members of the ABCA subfamily are related to the transmembrane transport of lipid molecules (60): e.g., cholesterol and phosphatidylcholine for ABCA1 (61), N-retinylidenephosphatidylethanolamine for ABCA4 (62), phosphatidylcholine for ABCA7 (63), and glucosylceramide for ABCA12 (64). The specific function and substrates of the ABCA13 protein have yet to be determined. However, on the basis of the high degree of sequence homology between ABCA members, ABCA13 is also hypothesized to function in lipid transport (11, 12) . Notably, one of the ABCA13 variants (T4031A) found in a study (12) severely impairs cholesterol efflux when tested in HEK 293 cells using ABCA1 as a template (11) (i.e., T4031A is reproduced in the corresponding amino acid residue of ABCA1). Thus, even single-nucleotide changes in ABCA13 could have a deleterious effect on the transport capacity of its protein. A number of studies have implicated abnormalities of lipid metabolism in schizophrenia (65-71) and ASD (72-75). We hypothesize, therefore, that the deletion of the ABCA13 gene in monkey E induced aberrant neuronal signaling via alterations of intracerebral lipid homeostasis, thereby causing social cognitive impairments that are seen in schizophrenia and ASD  clinical conditions that may lie on a spectrum with partly overlapping causes and symptoms (76) (77) (78) (79) (80) .
Relationships between HTR2C disruptions and mental disorders
HTR2C, located on the X chromosome, encodes the 5-hydroxytryptamine (5-HT or serotonin) subtype 2C receptor. This receptor is G-protein-coupled (81) and linked to phosphatidylinositol hydrolysis via phospholipase C activation (82). The 5-HT2c receptor is a prominent subtype of the serotonin receptor in the central nervous system, preferentially expressed in the choroid plexus, striatum, hippocampus, hypothalamus, olfactory tubercles, substantia nigra, amygdala, and neocortical areas (83-86). The heterogeneity of 5-HT2c receptors in the brain arises from three different sources: genetic polymorphism of the coding region (Cys23Ser) (87), alternative RNA splicing (85, 88) , and post-transcriptional adenosine-to-inosine RNA editing (89). The mutation identified in monkey E affected one isoform (i.e., the truncated isoform; see below) generated by alternative splicing.
The alternative splicing of HTR2C produces two different transcripts: the full-length receptor isoform and the truncated isoform. The truncated isoform is generated by a 95-nucleotide deletion at the 3' end of exon 5, a region coding for the putative second intracellular loop and the fourth transmembrane domain of the receptor (85, 88) . This deletion leads to a frameshift and a premature termination codon (85). With this frameshift, the truncated protein contains 19 and 96 unique amino acids on the carboxyl terminus in rodents and primates, respectively (85, 88) . The two isoforms are expressed in the same brain regions (85), but the truncated isoform is much less abundant (88), ranging from ~6% of the total expression level in the human brain (90) to ~20% in the rat striatum. The CT mutation in exon 6 observed in monkey E generated a stop codon in the unique carboxyl-terminal sequence and eliminated the last 70 amino acids of the truncated isoform.
The functional role of the truncated isoform has not been specified. The splice variants are conserved between rats, mice, and humans (85, 88), suggesting their possible biological significance in the generation of multiple receptor variants. Moreover, the expression level of the truncated isoform is substantially increased in choroid plexus tumor (88), glioblastoma tissues (29-35%) (90), and in glioma cell lines (100%) (90), which indicates a role for the truncated isoform in neuronal proliferation and/or differentiation. Furthermore, our own observation that the truncated isoform was a prominent transcript in the macaque brain during relatively early postnatal periods suggests that this isoform may play a critical role in neuronal development. It has been shown that the expression of the 5-HT2c (previously named 5-HT1c) receptor is developmentally regulated in the rat brain (91). Specifically, the expression level of 5-HT2c receptor mRNA increases fivefold between embryonic day 17 and postnatal day 13, which is consistent with the present study of the macaque brain ( Fig. 6C) , at least partly. It is noteworthy that in our study, the postnatal increase in the expression level of 5-HT2c receptor mRNA was ascribed to the increase in that of the truncated isoform. Although much work remains to be carried out in determining the neurobiological mechanisms whereby the truncated isoform affects the structure and function of the brain, the studies described above and our own suggest that the truncated isoform plays an important role in normal brain development.
The 5-HT2c receptor has been implicated in a range of neuropsychiatric disorders. Firstly, a study showed that mice lacking the 5-HT2c receptor exhibit eating disorder characterized by increased food intake and are also prone to spontaneous death from seizures (92) . Note that in that study, mutant mice were generated by introducing a nonsense mutation into exon 5, thereby eliminating the carboxy-terminal half of the receptor. Secondly, a brain-specific small nucleolar RNA, HBII-52, which regulates alternative splicing of the 5-HT2c receptor (93), is absent in patients with Prader-Willi syndrome (PWS) (93). The expression level of HBII-52 in mice with 15q11-13 duplication, which were developed as the model of ASD, is approximately twice that in control mice (2). Thirdly, the Cys23Ser polymorphism in the coding region of the HTR2C gene is associated with depression and bipolar disorder (16, 94, 95) , tardive dyskinesia in schizophrenia (96), and psychotic symptoms in late-onset Alzheimer's disease (97). Finally, post-transcriptional RNA editing of the 5-HT2c receptor is linked to PWS (93), suicidal behaviors with or without depression (15, 98, 99) , and the mouse model of ASD (2). It is notable again that the mutation of HTR2C identified in monkey E can lead to abnormalities in serotoninrelated neuronal signaling and development, which have been associated with neuropsychiatric disorders and ASD (100).
